Eastwood Bio-Medical Canada Inc (EBM) — Strategic Asset Allocation Index
Eastwood Bio-Medical Canada Inc (EBM) has a Strategic Asset Allocation Index of 1604.2% as of April 2021. Strategic assets (PP&E of CA$597.08K plus long-term investments of CA$-) total CA$597.08K, measured against net assets of CA$37.22K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how resilient are Eastwood Bio-Medical Canada Inc's assets to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Eastwood Bio-Medical Canada Inc Strategic Asset Allocation Index (2018–2020)
This chart shows how Eastwood Bio-Medical Canada Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2018 to 2020. As of April 2021, the index stands at 1604.2%, representing strategic assets of CA$597.08K against net assets of CA$37.22K CAD. See how financially flexible is Eastwood Bio-Medical Canada Inc to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Eastwood Bio-Medical Canada Inc (2018–2020)
The table below presents the year-by-year Strategic Asset Allocation Index for Eastwood Bio-Medical Canada Inc from 2018 to 2020, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Eastwood Bio-Medical Canada Inc (EBM) total market value.
| Year | SAAI | Strategic Assets (CAD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2020 | 141.4% | CA$649.58K | CA$649.58K | CA$- | CA$459.27K | ▲ +106.6 pp |
| 2019 | 34.8% | CA$456.60K | CA$456.60K | CA$- | CA$1.31 Million | ▲ +20.9 pp |
| 2018 | 13.9% | CA$262.59K | CA$262.59K | CA$- | CA$1.89 Million | — |